Mukai Kaori, Gaudenzio Nicolas, Gupta Sheena, Vivanco Nora, Bendall Sean C, Maecker Holden T, Chinthrajah Rebecca S, Tsai Mindy, Nadeau Kari C, Galli Stephen J
Department of Pathology, Stanford University School of Medicine, Stanford, Calif; Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, Calif.
Human Immune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, Calif.
J Allergy Clin Immunol. 2017 Mar;139(3):889-899.e11. doi: 10.1016/j.jaci.2016.04.060. Epub 2016 Jul 15.
Basophil activation tests (BATs) have promise for research and for clinical monitoring of patients with allergies. However, BAT protocols vary in blood anticoagulant used and temperature and time of storage before testing, complicating comparisons of results from various studies.
We attempted to establish a BAT protocol that would permit analysis of blood within 24 hours of obtaining the sample.
Blood from 46 healthy donors and 120 patients with peanut allergy was collected into EDTA or heparin tubes, and samples were stored at 4°C or room temperature for 4 or 24 hours before performing BATs.
Stimulation with anti-IgE or IL-3 resulted in strong upregulation of basophil CD203c in samples collected in EDTA or heparin, stored at 4°C, and analyzed 24 hours after sample collection. However, a CD63 population of basophils was not observed in any conditions in EDTA-treated samples unless exogenous calcium/magnesium was added at the time of anti-IgE stimulation. By contrast, blood samples collected in heparin tubes were adequate for quantification of upregulation of basophil CD203c and identification of a population of CD63 basophils, irrespective of whether the specimens were analyzed by means of conventional flow cytometry or cytometry by time-of-flight mass spectrometry, and such tests could be performed after blood was stored for 24 hours at 4°C.
BATs to measure upregulation of basophil CD203c and induction of a CD63 basophil population can be conducted with blood obtained in heparin tubes and stored at 4°C for 24 hours.
嗜碱性粒细胞活化试验(BATs)在过敏患者的研究和临床监测方面具有前景。然而,BAT方案在所用血液抗凝剂以及检测前的储存温度和时间方面存在差异,使得不同研究结果的比较变得复杂。
我们试图建立一种BAT方案,以便在获取样本后24小时内对血液进行分析。
将46名健康供者和120名花生过敏患者的血液采集到乙二胺四乙酸(EDTA)或肝素管中,样本在进行BATs之前于4°C或室温下储存4或24小时。
用抗IgE或白细胞介素-3刺激后,在EDTA或肝素中采集、于4°C储存并在样本采集后24小时进行分析的样本中,嗜碱性粒细胞CD203c出现强烈上调。然而,在EDTA处理的样本中,除非在抗IgE刺激时添加外源性钙/镁,否则在任何条件下均未观察到嗜碱性粒细胞的CD63群体。相比之下,无论样本是通过传统流式细胞术还是飞行时间质谱流式细胞术进行分析,采集于肝素管中的血液样本都足以定量嗜碱性粒细胞CD203c的上调情况并鉴定CD63嗜碱性粒细胞群体,并且此类检测可在血液于4°C储存24小时后进行。
测量嗜碱性粒细胞CD203c上调和诱导CD63嗜碱性粒细胞群体的BATs可使用采集于肝素管并于4°C储存24小时的血液进行。